-

Eurofins: Weekly Report on Share Repurchases From 01st December to 05th December 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:

Eurofins (Paris:ERF):

Name of the
Issuer

Identify code of the
Issuer

Transaction
day

Identify code of
the financial
instrument

Total daily
volume (in
number of
shares)

Daily
weighted
average
purchase
price of
the shares

Market
(MIC
Code)

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

12/01/2025

FR0014000MR3

20 000

58.9527

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

12/02/2025

FR0014000MR3

20 000

59.3808

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

12/03/2025

FR0014000MR3

20 000

58.8687

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

12/04/2025

FR0014000MR3

20 000

58.8292

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

12/05/2025

FR0014000MR3

20 000

58.9334

XPAR

 

 

 

TOTAL

100 000

58.9930

 

Transaction details

In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes

Contacts

Eurofins

Eurofins

BOURSE:ERF
Release Versions
English

Contacts

Eurofins

More News From Eurofins

The Eurofins Consumer Product Testing Network Completes Significant Laboratory Expansion in Vietnam

HO CHI MINH CITY, Vietnam--(BUSINESS WIRE)--Eurofins Consumer Product Testing Vietnam has completed a major expansion, seeing the laboratory move to a purpose-built 7,000 sq. m laboratory in Ho Chi Minh City. This new facility provides more than two and a half times the floor space of Eurofins Consumer Product Testing Vietnam’s previous site. This investment strengthens the Eurofins Consumer Product Testing network’s capability to deliver world-class testing solutions and supports Vietnam’s rap...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 November 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedi (including the issuer ID allocated by the CSSF EUROFINS SCIENTIFIC SE – E1013 Identity of t...

Eurofins Medical Device Services Launches first GMP PFAS Screening and Testing Solutions for Medical Devices

LANCASTER, Pa.--(BUSINESS WIRE)--Eurofins Medical Device Services North America, part of a global network of over 20 medical device testing laboratories and a leading medical device solutions partner, recently launched a GMP PFAS testing and screening solution, the first developed and commercialized for the medical device industry. This offering provides insights to medical device manufacturers as they navigate the complex and evolving global regulations surrounding PFAS, ultimately contributin...
Back to Newsroom